Imagion Biosystems Limited (IBX.AX)

AUD 0.01

(0.0%)

Operating Expenses Summary of Imagion Biosystems Limited

Imagion Biosystems Limited's latest annual operating expenses in 2023 was 15.53 Million AUD , up 22.3% from previous year.
Imagion Biosystems Limited's latest quarterly operating expenses in 2024 Q2 was 1.08 Million AUD , down 0.0% from previous quarter.
Imagion Biosystems Limited reported a annual operating expenses of 12.7 Million AUD in annual operating expenses 2022, up 43.2% from previous year.
Imagion Biosystems Limited reported a annual operating expenses of 8.87 Million AUD in annual operating expenses 2021, up 11.5% from previous year.
Imagion Biosystems Limited reported a quarterly operating expenses of 1.08 Million AUD for 2024 Q1, down -86.75% from previous quarter.
Imagion Biosystems Limited reported a quarterly operating expenses of 7.33 Million AUD for 2023 Q2, up 154.26% from previous quarter.

Annual Operating Expenses Chart of Imagion Biosystems Limited (2023 - 2014)

Historical Annual Operating Expenses of Imagion Biosystems Limited (2023 - 2014)

Year	Operating Expenses	Operating Expenses Growth
2023	15.53 Million AUD	22.3%
2022	12.7 Million AUD	43.2%
2021	8.87 Million AUD	11.5%
2020	7.95 Million AUD	35.29%
2019	5.88 Million AUD	-35.72%
2018	9.14 Million AUD	27.1%
2017	7.19 Million AUD	1220.88%
2016	544.93 Thousand AUD	-86.81%
2015	4.13 Million AUD	77.61%
2014	2.32 Million AUD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	1.08 Million AUD	0.0%
2024 Q1	1.08 Million AUD	-86.75%
2023 Q2	7.33 Million AUD	154.26%
2023 Q4	8.2 Million AUD	197.79%
2023 FY	15.53 Million AUD	22.3%
2023 Q1	2.88 Million AUD	-53.26%
2023 Q3	2.75 Million AUD	-62.43%
2022 Q3	2.45 Million AUD	-54.66%
2022 Q2	5.42 Million AUD	160.26%
2022 FY	12.7 Million AUD	43.2%
2022 Q1	2.08 Million AUD	-52.96%
2022 Q4	6.16 Million AUD	150.83%
2021 Q2	4.03 Million AUD	157.02%
2021 FY	8.87 Million AUD	11.5%
2021 Q4	4.43 Million AUD	192.62%
2021 Q1	1.57 Million AUD	-60.84%
2021 Q3	1.51 Million AUD	-62.48%
2020 Q1	1.19 Million AUD	-53.84%
2020 FY	7.95 Million AUD	35.29%
2020 Q4	4 Million AUD	188.87%
2020 Q3	1.38 Million AUD	-65.73%
2020 Q2	4.05 Million AUD	240.42%
2019 FY	5.88 Million AUD	-35.72%
2019 Q4	2.57 Million AUD	204.01%
2019 Q3	847.95 Thousand AUD	-74.65%
2019 Q2	3.34 Million AUD	243.32%
2019 Q1	974.21 Thousand AUD	-16.01%
2018 Q1	1.54 Million AUD	7.16%
2018 FY	9.14 Million AUD	27.1%
2018 Q4	1.15 Million AUD	0.0%
2018 Q3	1.15 Million AUD	-24.88%
2018 Q2	1.54 Million AUD	0.0%
2017 Q3	1.44 Million AUD	-34.4%
2017 FY	7.19 Million AUD	1220.88%
2017 Q2	2.19 Million AUD	-0.0%
2017 Q1	2.19 Million AUD	316.25%
2017 Q4	1.44 Million AUD	0.0%
2016 Q4	527.71 Thousand AUD	0.0%
2016 Q1	- AUD	0.0%
2016 FY	544.93 Thousand AUD	-86.81%
2016 Q2	- AUD	0.0%
2015 Q4	- AUD	0.0%
2015 FY	4.13 Million AUD	77.61%
2014 FY	2.32 Million AUD	0.0%

Peer Operating Expenses Comparison of Imagion Biosystems Limited

Name	Operating Expenses	Operating Expenses Difference
Australian Clinical Labs Limited	81.54 Million AUD	80.95%
BCAL Diagnostics Limited	8.54 Million AUD	-81.79%
Genetic Signatures Limited	4.3 Million AUD	-260.595%
Genetic Technologies Limited	3.9 Million AUD	-297.863%
Healius Limited	265.1 Million AUD	94.14%
Integral Diagnostics Limited	61.88 Million AUD	74.899%
INOVIQ Ltd	6.8 Million AUD	-128.22%
Microba Life Sciences Limited	5.9 Million AUD	-163.054%
Monash IVF Group Limited	91.1 Million AUD	82.95%
Rhythm Biosciences Limited	5.34 Million AUD	-190.371%
Sonic Healthcare Limited	1.49 Billion AUD	98.961%